Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti–PD-1/PD-L1 immunotherapy

Journal: Science Advances

Published: 2020-05-01

DOI: 10.1126/sciadv.aax7881

Affiliations: 5

Authors: 13

Go to article
Institutions Share
Luxembourg Institute of Health (LIH), Luxembourg 0.42
Sprint Bioscience AB, Sweden 0.35
Karolinska Institute (KI), Sweden 0.12
Abramson Cancer Center, Penn, United States of America (USA) 0.08
Centre Hospitalier de Luxembourg (CHL), Luxembourg 0.04